Before any chip reaches a customer, it must be tested to make sure it works, and Teradyne (NASDAQ:TER) makes the machines that do the testing. As artificial-intelligence chips and the memory that supports them proliferate, demand for that testing has surged, putting Teradyne at …
The vote covered the election of three Class I directors at Sohu.com Ltd (NASDAQ: SOHU)’s 2026 annual meeting.
PODLOGAR SUSAN M received 75,000 shares of Tevogen Inc. (NASDAQ: TVGN) on Sep 11 in a director award. The transaction was recorded under code A.
Feike Jeffrey L. received 75,000 Tevogen shares, taking his resulting holding to 131,435 shares. The transaction concerns the director’s ownership of Tevogen Inc (NASDAQ: TVGN).
The materials are intended for use either in full or in part during the event.
The meeting will take place online rather than in person, with shareholders able to vote electronically and submit questions during the session. The company’s proxy materials also report fiscal 2026 compensation actually paid to the principal executive officer and the average for non-PEO named …
Microsoft (NASDAQ:MSFT) has staked its next chapter on two things: the growth of its Azure cloud platform and the take-up of its Copilot artificial-intelligence assistants. ForNasdaq100 investors, those two measures have become the clearest test of whether the enormous sums being spent on AI …
Conexeu Sciences Inc. (NASDAQ: CNXU) director Jeffrey Sharpe holds an activist stake equal to 5.2% of the company’s outstanding common stock. His position consists of 1,500,000 shares and reflects ownership reported as of September 14, 2026. Sharpe acquired the securities through compensation arrangements and …
Strategy (NASDAQ:MSTR), the company formerly known as MicroStrategy, has become the most unusual member of theNasdaq100: a business-software company that has transformed itself into a giant, publicly traded holder of Bitcoin. Its strategy of borrowing and issuing shares to buy theCryptocurrencymakes Bitcoin exposure and …
Nistec Golan Ltd.’s stake in ELTEK LTD. (NASDAQ: ELTK) was reported at 60.23%, covering 4,047,659 ordinary shares. The position is identified in an activist Schedule 13D/A, and the filing states that the shares were originally acquired for investment purposes.